Introducing Allday® 5000 Sensitive Toothpaste, the latest addition to Elevate Oral Care’s innovative line of prescription-strength toothpastes. Allday 5000 Sensitive does not contain SLS or CAPB. It uses the same next-generation glycolipid surfactant…
Read More...
Unlicensed Dental Providers Put Patients and the Profession at Risk
Reports of unlicensed individuals performing dental procedures are on the rise, leaving patients financially and physically harmed…
Precision Begins With Diagnosis
Accurate diagnosis is the cornerstone of predictable full-arch rehabilitation, especially in complex maxillary cases where anatomy,…
Real, Lasting Change Happens on the Patient’s Terms
True behavior change doesn’t happen because we tell patients what to do, but rather it happens when they discover their own reasons…
CMS Rule Cements the Importance of Oral and Systemic Health Integration
A new Centers for Medicare & Medicaid Services policy marks a major step toward integrating dentistry and medicine. By adding…
Weekly Popular
Personal Finance
More Top Stories
Research Provides Key Insight Into Severe COVID-19 Illness
While advanced age and comorbidities are well-known risk factors for severe illness caused by COVID-19, it was still not understood why some people became gravely ill, whereas other patients of similar backgrounds recovered quickly.…
Can a New Drug Formulation Treat Candida Infections
Candida albicans infections in the mouth are often painful for people who develop infections such as burning mouth syndrome or thrush.
Pfizer Is Confident About Distribution of Its COVID-19 Vaccine
United States pharmaceutical giant, Pfizer, whose two-shot COVID-19 vaccine recently showed 90% effectiveness in preliminary studies, is ready to roll out millions of doses as soon as it receives approval from the US Food and Drug…
Does COVID-19 Increase Risk for Mental Illness?
A new study found that patients who recovered from COVID-19 were at elevated risk for mental illness. Published in the British medical journal The Lancet, results demonstrated that one in five patients who had recovered from a SARS-CoV-2…
FDA Provides EUA for COVID-19 Treatment
On November 9, the United States Food and Drug Administration issued an emergency use authorization (EUA) to bamlanivimab for the treatment of mild-to-moderate COVID-19. The monoclonal antibody therapy is authorized for COVID-19 patients…
Pfizer Takes the Lead in the Race to Develop a COVID-19 Vaccine
The American pharmaceutical company Pfizer reported that its COVID-19 vaccine is highly effective in preventing infection with the novel coronavirus in preliminary studies. In light of rising case numbers across the United States, this is…
Sunstar Americas, Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral…
Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the consumer level. This product may be…
Mutated Strain of Coronavirus Found in Danish Mink Population
A mutated version of the coronavirus has infected the farmed mink population in Denmark, the largest supplier of mink fur in the world. Thus far, the mutation has impacted more than 200 mink farms and over 200 Danes have been infected with…
Can a Nasal Spray Prevent COVID-19?
Columbia University researchers have developed a nasal spray designed to prevent infection with the novel coronavirus, and an initial study conducted on ferrets demonstrates efficacy. While the study was small and has not undergone peer…
FDA Takes Action Against Manufacturers of Products Making False COVID-19 Claims
The United States Food and Drug Administration (FDA) asked two companies to stop selling products due to false claims made about their ability to prevent and/or treat the illness associated with the novel coronavirus. The requests were…
Market Media
- Advertisement -
